Artículos de revistas sobre el tema "CBR AGENTS"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "CBR AGENTS".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Heras, Stella, Vicente Botti y Vicente Julián. "Challenges for a CBR framework for argumentation in open MAS". Knowledge Engineering Review 24, n.º 4 (diciembre de 2009): 327–52. http://dx.doi.org/10.1017/s0269888909990178.
Texto completoRobertson, Gregory T., Eric J. Bonventre, Timothy B. Doyle, Qun Du, Leonard Duncan, Timothy W. Morris, Eric D. Roche, Dalai Yan y A. Simon Lynch. "In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Studies of the Mode of Action in Staphylococcus aureus". Antimicrobial Agents and Chemotherapy 52, n.º 7 (julio de 2008): 2313–23. http://dx.doi.org/10.1128/aac.01649-07.
Texto completoNavarro, M., S. Heras, V. Julián y V. Botti. "Incorporating temporal-bounded CBR techniques in real-time agents". Expert Systems with Applications 38, n.º 3 (marzo de 2011): 2783–96. http://dx.doi.org/10.1016/j.eswa.2010.08.070.
Texto completoAydin, Burc. "Global Characteristics of Chemical, Biological, and Radiological Poison Use in Terrorist Attacks". Prehospital and Disaster Medicine 35, n.º 3 (2 de abril de 2020): 260–66. http://dx.doi.org/10.1017/s1049023x20000394.
Texto completoOltenfreiter, Ruth, Ludovicus Staelens, Soraya Labied, Veerle Kersemans, Francis Frankenne, Agnes Noël, Christophe Van de Wiele y Guido Slegers. "Tryptophane-Based Biphenylsulfonamide Matrix Metalloproteinase Inhibitors as Tumor Imaging Agents". Cancer Biotherapy and Radiopharmaceuticals 20, n.º 6 (diciembre de 2005): 639–47. http://dx.doi.org/10.1089/cbr.2005.20.639.
Texto completoHosseinimehr, Seyed Jalal. "Potential Utility of Radioprotective Agents in the Practice of Nuclear Medicine". Cancer Biotherapy and Radiopharmaceuticals 24, n.º 6 (diciembre de 2009): 723–31. http://dx.doi.org/10.1089/cbr.2009.0635.
Texto completoRosebrough, S. F. y D. F. Hartley. "Isothiocyanate-Trigalactose: Application for Antibody-Targeted Delivery of Diagnostic and Therapeutic Agents". Cancer Biotherapy and Radiopharmaceuticals 15, n.º 5 (octubre de 2000): 507–15. http://dx.doi.org/10.1089/cbr.2000.15.507.
Texto completoAhmed, Ishtiaq, Saif Ur Rehman, Shiva Shahmohamadnejad, Muhammad Anjum Zia, Muhammad Ahmad, Muhammad Muzammal Saeed, Zain Akram, Hafiz M. N. Iqbal y Qingyou Liu. "Therapeutic Attributes of Endocannabinoid System against Neuro-Inflammatory Autoimmune Disorders". Molecules 26, n.º 11 (3 de junio de 2021): 3389. http://dx.doi.org/10.3390/molecules26113389.
Texto completoSharma, Rakesh Kumar, Sudha Rana y Natarajan Gopalan. "Towards Protecting Critical National Assets and Preparedness for Response to Hazardous Chemical, Biological and Radiological Attacks". Defence Life Science Journal 4, n.º 4 (21 de octubre de 2019): 256–65. http://dx.doi.org/10.14429/dlsj.4.15134.
Texto completoRobertson, Gregory T., Timothy B. Doyle, Qun Du, Leonard Duncan, Khisimuzi E. Mdluli y A. Simon Lynch. "A Novel Indole Compound That Inhibits Pseudomonas aeruginosa Growth by Targeting MreB Is a Substrate for MexAB-OprM". Journal of Bacteriology 189, n.º 19 (20 de julio de 2007): 6870–81. http://dx.doi.org/10.1128/jb.00805-07.
Texto completoAziz, Emad F., Joseph E. Bugaj, Gül Caglar, Ludger M. Dinkelborg y Rüdiger Lawaczeck. "Novel Approach in Radionuclide Tumor Therapy: Dose Enhancement by High Z-Element Contrast Agents". Cancer Biotherapy and Radiopharmaceuticals 21, n.º 3 (junio de 2006): 181–93. http://dx.doi.org/10.1089/cbr.2006.21.181.
Texto completoKumar, Pardeep, Sushil Kumar Tripathi, Chang-Po Chen, Neil Mehta, Bishnuhari Paudyal, Eric Wickstrom y Mathew L. Thakur. "Evaluation of a PACAP Peptide Analogue Labeled with 68Ga Using Two Different Chelating Agents". Cancer Biotherapy and Radiopharmaceuticals 31, n.º 1 (febrero de 2016): 29–36. http://dx.doi.org/10.1089/cbr.2015.1947.
Texto completoCapala, Jacek, Julie A. Hong, Bhadrasain Vikram y C. Norman Coleman. "Neutron Capture Therapy: The Promise of Novel Agents and Medical Facility-Based Neutron Sources". Cancer Biotherapy and Radiopharmaceuticals 38, n.º 3 (1 de abril de 2023): 141–42. http://dx.doi.org/10.1089/cbr.2022.0098.
Texto completoAkbashev, Mikhail Y., Brian Michael Lingerfelt, Yuan Liu, Omer Kucuk, Viraj A. Master y Wayne Harris. "Utility of the modified Glasgow prognostic score in patients with metastatic renal cell carcinoma treated with targeted agents." Journal of Clinical Oncology 30, n.º 5_suppl (10 de febrero de 2012): 441. http://dx.doi.org/10.1200/jco.2012.30.5_suppl.441.
Texto completoHenriet, Julien, Christophe Lang, Ronnie Muthada Pottayya y Karla Breschi. "A SELF-ADAPTABLE DISTRIBUTED CBR VERSION OF THE EQUIVOX SYSTEM". Biomedical Engineering: Applications, Basis and Communications 28, n.º 04 (agosto de 2016): 1650028. http://dx.doi.org/10.4015/s1016237216500289.
Texto completoCaffo, Orazio, Viviana Frantellizzi, Fabio Monari, Luca Galli, Renato Patrizio Costa, Carmine Pinto, Marcello Tucci et al. "Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without 223Ra". Cancer Biotherapy and Radiopharmaceuticals 36, n.º 5 (1 de junio de 2021): 391–96. http://dx.doi.org/10.1089/cbr.2020.4442.
Texto completoSingh, Sweta, Anjani K. Tiwari, Himanshu Ojha, Nitin Kumar, Bachcha Singh y Anil K. Mishra. "SAR of Cu (II) Thiosemicarbazone Complexes as Hypoxic Imaging Agents: MM3 Analysis and Prediction of Biologic Properties". Cancer Biotherapy and Radiopharmaceuticals 25, n.º 1 (febrero de 2010): 117–21. http://dx.doi.org/10.1089/cbr.2009.0670.
Texto completoNonnekens, Julie, Kristell L. S. Chatalic, Janneke D. M. Molkenboer-Kuenen, Cecile E. M. T. Beerens, Frank Bruchertseifer, Alfred Morgenstern, Joke Veldhoven-Zweistra et al. "213Bi-Labeled Prostate-Specific Membrane Antigen-Targeting Agents Induce DNA Double-Strand Breaks in Prostate Cancer Xenografts". Cancer Biotherapy and Radiopharmaceuticals 32, n.º 2 (marzo de 2017): 67–73. http://dx.doi.org/10.1089/cbr.2016.2155.
Texto completoNugroho, Soewignjo Agus, Ferry Fatnanta y Muhammad Faizal Alridho. "EFFECT OF ADDING WOOD POWDER ASH ON CBR VALUE IN STABILIZED HIGH PLASTICITY CLAY CEMENT AND LIME". astonjadro 10, n.º 2 (17 de octubre de 2021): 301. http://dx.doi.org/10.32832/astonjadro.v10i2.5235.
Texto completoMeyer, Larissa A., Brian M. Slomovitz, Bojana Djordjevic, Shannon N. Westin, David A. Iglesias, Mark F. Munsell, Yunyun Jiang et al. "The Search Continues: Looking for Predictive Biomarkers for Response to Mammalian Target of Rapamycin Inhibition in Endometrial Cancer". International Journal of Gynecologic Cancer 24, n.º 4 (mayo de 2014): 713–17. http://dx.doi.org/10.1097/igc.0000000000000118.
Texto completoMuzzammil, Tassawwar, Malcolm J. Moore y James R. Ballinger. "In Vitro Comparison of Sestamibi, Tetrofosmin, and Furifosmin as Agents for Functional Imaging of Multidrug Resistance in Tumors". Cancer Biotherapy and Radiopharmaceuticals 15, n.º 4 (agosto de 2000): 339–46. http://dx.doi.org/10.1089/cbr.2000.15.339.
Texto completoLee, Jii Bum, Hyung Soon Park, Su Jin Choi, Seong Gu Heo, Ho Jung An, Hye Ryun Kim, Min Hee Hong et al. "Plasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapy". Therapeutic Advances in Medical Oncology 14 (enero de 2022): 175883592211417. http://dx.doi.org/10.1177/17588359221141761.
Texto completoIftikhar, Ahmad, Hamza Hassan, Nimra Iftikhar, Adeela Mushtaq, Atif Sohail, Nathaniel Rosko, Rajshekhar Chakraborty et al. "Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical Development". Antibodies 8, n.º 2 (24 de mayo de 2019): 34. http://dx.doi.org/10.3390/antib8020034.
Texto completoSchepetkin, Igor. "Immune Response to Haptenized Tumor Antigen as Possible Mechanism of Anticancer Action of Hypoxic Bioreductive Agents at Low Doses". Cancer Biotherapy and Radiopharmaceuticals 14, n.º 4 (agosto de 1999): 291–96. http://dx.doi.org/10.1089/cbr.1999.14.291.
Texto completoKotts, C. E., F. M. Su, C. Leddy, T. Dodd, S. Scates, M. R. Shalaby, C. M. Wirth et al. "186Re-Labeled Antibodies to p185HER2as HER2-Targeted Radioimmunopharmaceutical Agents: Comparison of Physical and Biological Characteristics with125I and131I-Labeled Counterparts". Cancer Biotherapy and Radiopharmaceuticals 11, n.º 2 (abril de 1996): 133–44. http://dx.doi.org/10.1089/cbr.1996.11.133.
Texto completoGonzález, Carolina, Juan Carlos Burguillo, Martín Llamas y Rosalía Laza. "Designing Intelligent Tutoring Systems: A Personalization Strategy using Case-Based Reasoning and Multi-Agent Systems". ADCAIJ: Advances in Distributed Computing and Artificial Intelligence Journal 2, n.º 1 (7 de mayo de 2013): 41–54. http://dx.doi.org/10.14201/adcaij2013244154.
Texto completoOkarvi, Subhani M. y Ibrahim A. Jammaz. "Preparation and In Vitro and In Vivo Evaluation of Technetium-99m-Labeled Folate and Methotrexate Conjugates as Tumor Imaging Agents". Cancer Biotherapy and Radiopharmaceuticals 21, n.º 1 (febrero de 2006): 49–60. http://dx.doi.org/10.1089/cbr.2006.21.49.
Texto completoVandenbulcke, Katia, Hubert Thierens, Filip De Vos, Jan Philippé, Fritz Offner, Ann Janssens, Christos Apostolidis et al. "In VitroScreening for Synergism of High-Linear Energy Transfer213Bi-Radiotherapy with Other Therapeutic Agents for the Treatment of B-Cell Chronic Lymphocytic Leukemia". Cancer Biotherapy and Radiopharmaceuticals 21, n.º 4 (agosto de 2006): 364–72. http://dx.doi.org/10.1089/cbr.2006.21.364.
Texto completoOlugbenga Oludolapo Amu, Christopher Ehizemhen Igibah, Bamitale Dorcas Oluyemi-Ayibiowu y Lucia Omolayo Agashua. "Effect of triaxial and CBR Scrutiny on mechanical strength and microstructure of kaolin clay powder mixed SSA geopolymer and its performance at various percentages". World Journal of Engineering and Technology Research 1, n.º 1 (30 de enero de 2022): 011–20. http://dx.doi.org/10.53346/wjetr.2022.1.1.0024.
Texto completoBamitale Dorcas Oluyemi-Ayibiowu, Lucia Omolayo Agashua, Ehizemhen Christopher Igibah, Olugbenga Oludolapo Amu, Adedapo Oluwaseun Adetayo, Olumuyiwa Samson Aderinola y Tochukwu Ernest Ugochukwu. "Impact of sodium silicate with normal pH on mechanical strength of rice husk blend geopolymer and its performance at various percentages". World Journal of Advanced Science and Technology 1, n.º 2 (30 de junio de 2022): 001–10. http://dx.doi.org/10.53346/wjast.2022.1.2.0027.
Texto completoMa, Zhuo, Lifang Guo, Xiangli Cui, He Liu y Lihong Liu. "Rh-endostatin Concomitant with Chemotherapy Versus Single Agent Chemotherapy for Treating Soft Tissue and Bone Sarcomas: A Systematic Review and Meta-Analysis". Journal of Pharmacy & Pharmaceutical Sciences 21 (23 de octubre de 2018): 386–97. http://dx.doi.org/10.18433/jpps30034.
Texto completoForero, Andres, Ruby F. Meredith, M. B. Khazaeli, Sui Shen, William E. Grizzle, Delicia Carey, Elizabeth Busby, Albert F. LoBuglio y Francisco Robert. "Phase I Study of 90Y-CC49 Monoclonal Antibody Therapy in Patients with Advanced Non-Small Cell Lung Cancer: Effect of Chelating Agents and Paclitaxel Co-Administration". Cancer Biotherapy and Radiopharmaceuticals 20, n.º 5 (octubre de 2005): 467–78. http://dx.doi.org/10.1089/cbr.2005.20.467.
Texto completoxie, ping, Siqi Chen, Mathew Cowan, Hao Huang, Horacio Cardenas, Masha Kocherginsky, Daniela Matei y Bin Zhang. "Immune characterization in platinum resistant ovarian cancer patients treated with pembrolizumab and guadecitabine". Journal of Immunology 208, n.º 1_Supplement (1 de mayo de 2022): 119.15. http://dx.doi.org/10.4049/jimmunol.208.supp.119.15.
Texto completoByrd, Kenneth, Panduka Nagahawatte, Michael Gary Martin, Matthew K. Stein, Kruti Patel, Lee Steven Schwartzberg y Ari M. Vanderwalde. "Correlation between PD-L1 expression level and clinical benefit in 204 patients across malignancies at a single institution." Journal of Clinical Oncology 35, n.º 15_suppl (20 de mayo de 2017): e14573-e14573. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e14573.
Texto completoTripathi, AN, Rajesh Kumar Singh y SK Tiwari. "Evaluation of bio-control agents and new fungicides to control Pythium damping off in nursery of solanaceous vegetable crops". Vegetable Science 49, n.º 01 (30 de junio de 2022): 91–95. http://dx.doi.org/10.61180/vegsci.2022.v49.i1.14.
Texto completoGuleria, Mohini, Tapas Das, Jeyachitra Amirdhanayagam, Haladhar D. Sarma y Ashutosh Dash. "Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of 68Ga-Labeled Porphyrin: Impact on Pharmacokinetics and Tumor Uptake in a Mouse Model". Cancer Biotherapy and Radiopharmaceuticals 33, n.º 1 (febrero de 2018): 8–16. http://dx.doi.org/10.1089/cbr.2017.2337.
Texto completoHarianto, Tri. "Performance of Subbase Layer with Geogrid Reinforcement and Zeolite-Waterglass Stabilization". Civil Engineering Journal 8, n.º 2 (1 de febrero de 2022): 251–62. http://dx.doi.org/10.28991/cej-2022-08-02-05.
Texto completoRabbanifar, Saeed, Thi Thuy Minh Nguyen, Qin Qian, Nicholas A. Brake, Kyle Kibodeaux, Harold E. Crochet, Soheil Oruji et al. "Reusing Dredged Material through Stabilization with So-Called Bio-Enzyme Products". Buildings 13, n.º 10 (17 de octubre de 2023): 2618. http://dx.doi.org/10.3390/buildings13102618.
Texto completoZhu, Anjie, Peng Yuan, Jiayu Wang, Fei Ma, Yang Luo, Ying Fan, Qing LI, Pin Zhang y Binghe Xu. "A real-world retrospective study of apatinib plus chemotherapy in metastatic breast cancer." Journal of Clinical Oncology 35, n.º 15_suppl (20 de mayo de 2017): e12507-e12507. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e12507.
Texto completoRadwan, Mohammed K. H., Foo Wei Lee, Yoke Bee Woon, Ming Kun Yew, Kim Hung Mo y Soon Han Wai. "A Study of the Strength Performance of Peat Soil: A Modified Cement-Based Stabilization Agent Using Fly Ash and Polypropylene Fiber". Polymers 13, n.º 23 (23 de noviembre de 2021): 4059. http://dx.doi.org/10.3390/polym13234059.
Texto completoZhao, Yannan, Ning Xie, Wei Li, Wenyan Chen, Zheng Lv, Yabing Zheng, Tao Sun et al. "Real-world effectiveness of eribulin in heavily pretreated patients with metastatic breast cancer in China: A multicenter retrospective study." Journal of Clinical Oncology 39, n.º 15_suppl (20 de mayo de 2021): e13057-e13057. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e13057.
Texto completoWiberg, Nils, Ch M. M. Finger, T. Passler, S. Wagner y K. Polborn. "Zur Erzeugung von Silaethenen des Typus R2Si=CH(SiR3 ) und R2Si=CH2 durch thermische Salzeliminierung sowie zur Kenntnis von R2Si=CH(SitBu3) (R = Me, tBu ) / On the Generation of Silaethenes of the Types R2Si=CH(SiR3) and R2Si=CH2 by Thermal Salt Elimination and on the Knowledge of R2Si=CH(SitBu3) (R = Me, tBu)". Zeitschrift für Naturforschung B 51, n.º 12 (1 de diciembre de 1996): 1744–60. http://dx.doi.org/10.1515/znb-1996-1212.
Texto completovan Rhee, Frits, Luis Fayad, Peter Voorhees, Richard Furman, Sagar Lonial, Hossein Borghaei, Lubomir Sokol et al. "Siltuximab, a Novel Anti–Interleukin-6 Monoclonal Antibody, for Castleman's Disease". Journal of Clinical Oncology 28, n.º 23 (10 de agosto de 2010): 3701–8. http://dx.doi.org/10.1200/jco.2009.27.2377.
Texto completoZhao, Yannan, Ning Xie, Wei Li, Wenyan Chen, Zheng Lv, Yabing Zheng, Tao Sun et al. "Real-world effectiveness of eribulin in heavily pretreated patients with metastatic breast cancer in China: a multicenter retrospective study". Therapeutic Advances in Medical Oncology 13 (enero de 2021): 175883592110302. http://dx.doi.org/10.1177/17588359211030210.
Texto completoSandeep, K. Venkata Surya y Ch Sivanarayana. "An Experimental Study on Stabilization of Expansive Soil by Copper Slag". International Journal for Research in Applied Science and Engineering Technology 10, n.º 11 (30 de noviembre de 2022): 431–42. http://dx.doi.org/10.22214/ijraset.2022.47340.
Texto completoColombo, N., S. McMeekin, P. Schwartz, J. Kostka, C. Sessa, P. Gehrig, R. Holloway, P. Braly, D. Matei y M. Einstein. "A phase II trial of the mTOR inhibitor AP23573 as a single agent in advanced endometrial cancer". Journal of Clinical Oncology 25, n.º 18_suppl (20 de junio de 2007): 5516. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.5516.
Texto completoSingh, Jasmeet Chadha, Stacy Stein, Matthew Volm, Julia Anne Smith, Sylvia Adams, Marlene Meyers, James L. Speyer et al. "RAD001-carboplatin combination in triple-negative metastatic breast cancer (TNMBC): A phase II trial." Journal of Clinical Oncology 31, n.º 15_suppl (20 de mayo de 2013): 1042. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1042.
Texto completoKulcsár, Gyula. "Experimental Evidence for Killing the Resistant Cells and Raising the Efficacy and Decreasing the Toxicity of Cytostatics and Irradiation by Mixtures of the Agents of the Passive Antitumor Defense System in the Case of Various Tumor and Normal Cell Lines in Vitro". Cancer Biotherapy and Radiopharmaceuticals 24, n.º 1 (febrero de 2009): 67–80. http://dx.doi.org/10.1089/cbr.2008.0561.
Texto completoSoto, Juan José, Carlos Erasun Lecuona, Sandra Llop Serna, Nuria Mulet Margalef, Agostina Stradella, Rafael Villanueva, Mariona Calvo Campos et al. "Outcomes of patients (pts) treated with novel immunotherapy (IT) agents in phase 1 clinical trials (Ph1-CT) at early lines for advanced disease." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junio de 2022): 2581. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.2581.
Texto completoVincent, Azunna Chukwuma y Chiedozie F. Ikebude. "A Comparative Study on the Stabilization of Soft Soil Using Agricultural Wastes (Baggase Ash (BA) And Rice Husk Ash (RHA)". International Journal of Civil Engineering, Construction and Estate Management 11, n.º 2 (15 de febrero de 2023): 39–69. http://dx.doi.org/10.37745/ijcecem.14/vol11n23969.
Texto completo